Brian Doubles, Synchrony CEO since 2021, told Fortune that "it takes years to earn trust, but you can lose it in seconds." ...
Epicrispr Biotechnologies (“Epicrispr”), a clinical-stage company pioneering gene-modulating therapies, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and member of the ...
The University of Indianapolis today announced the launch of UIndy Online to expand access to affordable and flexible ...